Palo Alto Investors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.3M | Sell |
|
|||||
|
2025
Q1 | $44.2M | Sell |
|
|||||
|
2024
Q4 | $50.4M | Buy |
|
|||||
|
2024
Q3 | $38.8M | Buy |
|
|||||
|
2024
Q2 | $39.3M | Buy |
|
|||||
|
2024
Q1 | $44.7M | Buy |
|
|||||
|
2023
Q4 | $75.4M | Buy |
|
|||||
|
2023
Q3 | $50.1M | Hold |
|
|||||
|
2023
Q2 | $57.6M | Hold |
|
|||||
|
2023
Q1 | $45.3M | Buy |
|
|||||
|
2022
Q4 | $37.8M | Buy |
|
|||||
|
2022
Q3 | $27.5M | Hold |
|
|||||
|
2022
Q2 | $23.6M | Sell |
|
|||||
|
2022
Q1 | $54.5M | Sell |
|
|||||
|
2021
Q4 | $54.6M | Hold |
|
|||||
|
2021
Q3 | $38.8M | Hold |
|
|||||
|
2021
Q2 | $57M | Hold |
|
|||||
|
2021
Q1 | $60.3M | Buy |
|
|||||
|
2020
Q4 | $123M | Buy |
|
|||||
|
2020
Q3 | $75.6M | Buy |
|
|||||
|
2020
Q2 | $75.9M | Sell |
|
|||||
|
2020
Q1 | $68.9M | Sell |
|
|||||
|
2019
Q4 | $81.5M | Sell |
|
|||||
|
2019
Q3 | $78.3M | Sell |
|
|||||
|
2019
Q2 | $61.7M | Buy |
|
|||||
|
2019
Q1 | $60.4M | Buy |
|
|||||
|
2018
Q4 | $32.8M | Buy |
|
|||||
|
2018
Q3 | $35M | Buy |
|
|||||
|
2018
Q2 | $25.2M | Hold |
|
|||||
|
2018
Q1 | $37.1M | Buy |
|
|||||
|
2017
Q4 | $49.4M | Hold |
|
|||||
|
2017
Q3 | $61.8M | Buy |
|
|||||
|
2017
Q2 | $45M | Buy |
|
|||||
|
2017
Q1 | $54.7M | Buy |
|
|||||
|
2016
Q4 | $44.2M | Buy |
|
|||||
|
2016
Q3 | $47.1M | Buy |
|
|||||
|
2016
Q2 | $46.7M | Buy |
|
|||||
|
2016
Q1 | $13.6M | Buy |
|